Page 63 - Prostate News Today

The COVID-19 pandemic influenced cancer incidence.

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

​A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.

Health and wellness brand Aneros has officially launched the Prostate Health and Awareness Special Edition Blue Maximus Syn Trident and the Blue Prelude Enema Bulb Special Edition as National Prostate Cancer Awareness Month begins.

Men who are often advocates women for women’s health during Breast Cancer Awareness Month in October often forget to take care of themselves in September.

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.

Measuring biochemical recurrence (BCR) as a surrogate marker produces unreliable results as a primary end point for overall survival of patients with localized prostate cancer, a study found.

Prostate cancer referrals have spiked following the death last year of BBC presenter Bill Turnbull, who fought a prolonged battle with the disease.

In this special episode, host Julie Rovner, KFF Health News' chief Washington correspondent, interviews three noted health policy experts.

Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to side-effects of treatment.